Page last updated: 2024-10-15

acetylcarnitine and Cystic Fibrosis of Pancreas

acetylcarnitine has been researched along with Cystic Fibrosis of Pancreas in 1 studies

Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.

Research Excerpts

ExcerptRelevanceReference
"Acylcarnitine is low in cord blood in patients with cystic fibrosis, suggesting that fatty acid metabolism is disturbed in utero."7.68Carnitine metabolites in infants with cystic fibrosis: a prospective study. ( Lloyd-Still, JD; Powers, CA; Wessel, HU, 1993)
"Acylcarnitine is low in cord blood in patients with cystic fibrosis, suggesting that fatty acid metabolism is disturbed in utero."3.68Carnitine metabolites in infants with cystic fibrosis: a prospective study. ( Lloyd-Still, JD; Powers, CA; Wessel, HU, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lloyd-Still, JD1
Powers, CA1
Wessel, HU1

Other Studies

1 other study available for acetylcarnitine and Cystic Fibrosis of Pancreas

ArticleYear
Carnitine metabolites in infants with cystic fibrosis: a prospective study.
    Acta paediatrica (Oslo, Norway : 1992), 1993, Volume: 82, Issue:2

    Topics: Acetylcarnitine; Age Factors; Carnitine; Child, Preschool; Cystic Fibrosis; Energy Metabolism; Human

1993